Cancer Care Ontario | Cancer Care Ontario

1913 Results

Biosimilars - What You Need to Know

About Pathway Maps

Statistical Reports

Cancer Risk Factors in Ontario: Evidence Summary

Mar 2013

Guidelines and Advice

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Status: Current
ID: ES 23-2
Version: N/A

Jun 2020

Guidelines and Advice

Stem Cell Transplantation in Multiple Myeloma

Status: In-Review
ID: SCT 1

Mar 2012

Focal Tumour Ablation

Get Checked for Cancer

Cancer screening can find abnormal cell changes before they become cancer or cancer at an early stage, when treatment has a better chance of working...

South West Regional Cancer Program

Guidelines and Advice

Stem Cell Transplantation in Lymphoma

Status: Archived
ID: SCT 4

Dec 2012

Stem Cell Transplant Program

Guidelines and Advice

Ontario Health (Cancer Care Ontario) Endorsement of ASCO Rapid Recommendation on 177Lutetium-Prostate-Specific Membrane Antigen-617 (PSMA-617) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Status: Current
ID: GL-END 3-25

Nov 2023

Biosimilars - What You Need to Know

About Pathway Maps

Cancer Risk Factors in Ontario: Evidence Summary

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Stem Cell Transplantation in Multiple Myeloma

Focal Tumour Ablation

Get Checked for Cancer

South West Regional Cancer Program

Stem Cell Transplantation in Lymphoma

Stem Cell Transplant Program

Ontario Health (Cancer Care Ontario) Endorsement of ASCO Rapid Recommendation on 177Lutetium-Prostate-Specific Membrane Antigen-617 (PSMA-617) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Chimeric Antigen Receptor (CAR) T-cell Therapy Services

Pages